Nosh.bio develops fermented fungi-based ingredients designed to serve as single-ingredient meat analogs and other food applications. Its first commercial product, Koji Chunks, uses a non-GMO, non-novel fermented fungi ingredient and will be sold in five flavours. The company was founded in February 2022 and operates from a former brewery to accelerate route to market and reduce operating costs. Nosh.bio has secured fresh investment from new backers and strategic partners, enabling it to scale commercialisation efforts. Its fermentation process is adaptable for applications beyond meat analogs, including seafood, confectionery, sauces, and health & wellness products. A commercial partnership with zur Mühlen Group will initially bring Koji Chunks to German retailers through ZMG’s network, supporting mass-market adoption. Nosh.bio’s mission is “Sustainable Nutrition Made Affordable,” focusing on developing sustainable, animal‑free proteins. The company pursued seed funding to advance its product and narrative amid a challenging investment climate. In April 2023 Nosh.bio completed a €3.2M round. Fundraising strategy emphasized a clear equity story, a curated hit list of 100 investors, and leveraging industry insiders to open doors. CEO Tim Fronzek stressed frequent engagement with the cap table—weekly investor meetings and regular requests for introductions—to secure commitments. The company’s public messaging centers on aligning investors with the vision of affordable, animal‑free nutrition.

Total raised

$4M

Funding rounds

2

Latest round

Seed

Latest activity

Apr 2023